ADMA Biologics Inc (ADMA)
20.21
-1.26
(-5.89%)
USD |
NASDAQ |
Nov 14, 16:00
20.17
-0.04
(-0.20%)
After-Hours: 20:00
ADMA Biologics Cash from Investing (Quarterly): -1.098M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.098M |
| June 30, 2024 | -2.365M |
| March 31, 2024 | -2.362M |
| December 31, 2023 | -1.407M |
| September 30, 2023 | -0.757M |
| June 30, 2023 | -0.872M |
| March 31, 2023 | -1.945M |
| December 31, 2022 | -3.748M |
| September 30, 2022 | -3.380M |
| June 30, 2022 | -3.940M |
| March 31, 2022 | -2.842M |
| December 31, 2021 | -3.676M |
| September 30, 2021 | -2.789M |
| June 30, 2021 | -4.476M |
| March 31, 2021 | -2.571M |
| December 31, 2020 | -3.598M |
| September 30, 2020 | -2.885M |
| June 30, 2020 | -4.168M |
| March 31, 2020 | -2.073M |
| December 31, 2019 | -1.594M |
| September 30, 2019 | -1.972M |
| June 30, 2019 | -0.1352M |
| March 31, 2019 | -0.1105M |
| December 31, 2018 | -0.819M |
| September 30, 2018 | -0.2302M |
| Date | Value |
|---|---|
| June 30, 2018 | -0.4971M |
| March 31, 2018 | -0.5492M |
| December 31, 2017 | -2.010M |
| September 30, 2017 | -0.5699M |
| June 30, 2017 | 12.65M |
| March 31, 2017 | 5.142M |
| December 31, 2016 | 5.626M |
| September 30, 2016 | 0.2389M |
| June 30, 2016 | -8.617M |
| March 31, 2016 | 3.656M |
| December 31, 2015 | 5.401M |
| September 30, 2015 | 4.157M |
| June 30, 2015 | -4.426M |
| March 31, 2015 | -6.874M |
| December 31, 2014 | 1.111M |
| September 30, 2014 | -1.402M |
| June 30, 2014 | -4.369M |
| March 31, 2014 | 0.6202M |
| December 31, 2013 | -2.941M |
| September 30, 2013 | -0.0164M |
| June 30, 2013 | -0.1087M |
| March 31, 2013 | -0.0661M |
| December 31, 2012 | -0.0353M |
| September 30, 2012 | -0.0274M |
| June 30, 2012 | -0.0562M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-4.476M
Minimum
Jun 2021
-0.757M
Maximum
Sep 2023
-2.627M
Average
-2.680M
Median
Cash from Investing (Quarterly) Benchmarks
| Corcept Therapeutics Inc | -44.04M |
| Madrigal Pharmaceuticals Inc | -202.39M |
| Assembly Biosciences Inc | 5.107M |
| TG Therapeutics Inc | -9.334M |
| Krystal Biotech Inc | -34.33M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 25.03M |
| Cash from Financing (Quarterly) | -25.47M |
| Free Cash Flow | 78.82M |
| Free Cash Flow Per Share (Quarterly) | 0.0978 |
| Free Cash Flow to Equity (Quarterly) | 53.68M |
| Free Cash Flow to Firm (Quarterly) | 26.70M |
| Free Cash Flow Yield | 1.64% |